Skip to main content
Professional Technical IVT

ASCOT study

Also written as: ASCOT — Anglo-Scandinavian Cardiac Outcomes Trial

Landmark Anglo-Scandinavian Cardiac Outcomes Trial comparing blood pressure and lipid-lowering strategies.

Full Definition

The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) was a major randomized controlled trial that demonstrated the cardiovascular benefits of amlodipine-based blood pressure treatment and atorvastatin therapy. The study significantly influenced modern cardiovascular prevention guidelines by showing superior outcomes with newer antihypertensive regimens compared to traditional beta-blocker and diuretic combinations. ASCOT's findings regarding statin therapy in patients with normal cholesterol levels helped establish the role of statins in primary prevention.

Usage

Usage note: Often abbreviated in clinical literature; distinguish from ASCVD terminology.

In Context

  • "The ASCOT study demonstrated that amlodipine-based treatment was superior to atenolol-based treatment for reducing cardiovascular events." — Clinical research manuscript
  • "Guidelines frequently cite ASCOT findings when recommending calcium channel blockers over beta-blockers as first-line therapy." — Treatment guideline document

Also known as

Anglo-Scandinavian Cardiac Outcomes Trial

Don't confuse with

ASCVD ASCVD Risk Calculator

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON